ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Adverse Events of Over-Immunosuppression Are Dependent on Tofacitinib Exposure in Kidney Transplant (KT) Patients

    S. Busque, F. Vincenti, H. Tedesco Silva, P. O'Connell, M. Tortorici, N. Lawendy, W. Wang, G. Chan

    Stanford Univ, Stanford; UCSF, San Francisco; Hosp do Rim e Hipertensao, Sao Paulo, Brazil; Westmead Hosp, Westmead, Australia; Pfizer, Groton

    Background: In a prior Phase 2b study in de novo KT pts, a CNI-free tofacitinib fixed-dose regimen achieved comparable rate of biopsy-proven acute rejection (BPAR),…
  • 2013 American Transplant Congress

    Donor CD4 T Cells Trigger Costimulation Blockade-Resistant Donor Bone Marrow Rejection through Bystander Activation Requiring Interleukin 6

    K. Hock, N. Pilat, U. Baranyi, B. Mahr, C. Klaus, M. Gattringer, T. Wekerle

    Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria

    Background:Donor T cells have pleiotropic effects in allogeneic bone marrow transplantation (BMT). Co-transplanting high doses of donor T cells with donor BM causes rejection of…
  • 2013 American Transplant Congress

    Mycophenolic Acid (MPA) Dosing: Effect on Efficacy to 4 Years after Kidney Transplantation in the Mycophenolic Acid Observational Renal Transplant (MORE) Study

    L. Chan, F. Shihab, O. Pankewycz, C. Doria, A. Wiland, K. McCague, A. Langone

    University of Colorado School of Medicine, Aurora, CO; University of Utah School of Medicine, Salt Lake City, UT; Erie County Medical Center, Buffalo, NY; Thomas Jefferson University Hospital, Philadelphia, PA; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Vanderbilt University Medical Center, Nashville, TN

    Maintaining adequate MPA dose may be important to optimize efficacy after kidney transplantation, but prospective long-term data are rare.Methods. MORE was a prospective, observational study…
  • 2013 American Transplant Congress

    Epigenetic Analysis of the TSDR of FOXP3 Demonstrates That Natural Treg Infiltrate the Cardiac Allograft Already before an Acute Rejection Episode

    K. Boer, A. Peeters, A. Maat, K. Caliskan, A. Balk, W. Weimar, C. Baan

    Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands; Thoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands; Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands

    IntroductionTwo subtypes of FOXP3+ regulatory T cells (Treg) have been identified. Natural (n) Treg originate in the thymus, while antigen specific induced (i) Treg are…
  • 2013 American Transplant Congress

    How To Handle a Missed or Delayed Dose Intake? A Pharmacokinetic Study of Cyclosporine and Tacrolimus in Renal Transplant Patients

    F. Saint-Marcoux, J. Woillard, J. Friedl, F. Bocquentin, M. Essig, P. Marquet

    Pharmacology, CHU Limoges, Limoges, France; INSERM UMR-S850, Univ. Limoges, Limoges, France; Nephrology, CHU Limoges, Limoges, France

    BACKGROUND and OBJECTIVES: Despite the efforts made to optimize adherence, every transplant patient will, at least occasionally, miss doses or take them outside the prescribed…
  • 2013 American Transplant Congress

    Natural History of the Arteriovenous Access and Risk Factors Affecting Spontaneous Closure after Successful Kidney Transplantation, The

    J. Kim, J. Hwang, S. Park, C. Yang, I. Moon

    Surgery, The Catholic University of Korea, Seoul, Republic of Korea; Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea

    Purpose; After successful kidney transplantation (KT), arteriovenous access (AVA) is neither used nor useful. There are many debates whether to preserve an AVA or to…
  • 2013 American Transplant Congress

    Does African American (AA) Ethnicity Affect Kidney Transplant Outcomes at Four Years? An Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Study

    M. Narayanan, O. Pankewycz, F. Shihab, A. Wiland, K. McCague, L. Chan

    Scott and White Healthcare, Temple, TX; Erie County Medical Center, Buffalo, NJ; University of Utah School of Medicine, Salt Lake City, UT; Novartis Pharmaceuticals Corporation, East Hanover, NJ; University of Colorado School of Medicine, Aurora, CO

    Prospective data regarding kidney transplant outcomes in AA kidney transplant patients using modern immunosuppressive regimens are limited.Methods: MORE was a 4-year, prospective, observational study at…
  • 2013 American Transplant Congress

    Cost of Sepsis in a Program Utilizing Indefinite Sulfamethoxazole-Trimethoprim Prophylaxis in Renal Transplant Recipients

    T. Horwedel, L. Bowman, D. Brennan

    Pharmacy, Barnes-Jewish Hospital, St. Louis, MO; Medicine, Washington University, St. Louis, MO

    Background: Sepsis represents a significant cost and disease burden to the renal transplant recipient, adversely impacting both patient and graft survival. Sulfamethoxazole-trimethoprim (SMX-TMP) is a…
  • 2013 American Transplant Congress

    Outcomes of Transplantation for Uncontrolled HCC and Rescue with Marginal Quality Grafts

    P. Porrett, E. Baranov, A. Shaked, K. Olthoff

    Surgery, University of Pennsylvania, Philadelphia, PA

    Introduction We examined the survival of patients transplanted for progressive hepatocellular cancer (HCC) not controlled with locoregional therapy (LRT) and the impact of the strategy…
  • 2013 American Transplant Congress

    Liver Transplantation for Severe Hepatopulmonary Syndrome

    J. Lohlun, C. Mingmalairak, J. Lake, R. Kandaswamy, W. Payne, T. Pruett, S. Chinnakotla

    Department of Surgery, Division of Solid Organ Transplantation, University of Minnesota, Minneapolis, MN

    Background:Liver transplantation (LT) for hepatopulmonary syndrome (HPS) is well established. However, the outcomes of LT in severe HPS are not widely reported.Methods:Review of a Liver…
  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences